Rapid decrease of GAD 67 content before the convulsion induced by hyperbaric oxygen exposure.
Exposure to hyperbaric oxygen (HBO) can lead to seizures, the etiology of which is not completely understood. Glutamic acid decarboxylase (GAD) plays a very important role in maintaining excitatory-inhibitory balance of the central nervous system (CNS). In the present study we investigated the effects of HBO on the activity and content of GAD in vivo and in primarily cultured neurons to probe in detail its effect on the formation of convulsion induced by HBO exposure. The results obtained from in vivo and in vitro experiments were identical. In the latent period before the onset of seizure, the GAD activity followed a rise-and-fall pattern with the prolongation of HBO exposure. At the time of the onset of seizure, GAD activity descended to the normal level. Besides, in the latent period, GAD content also reduced. Such reduction came from a GAD subtype, GAD67, while the content of another GAD subtype, GAD65, remained almost unchanged. Our investigations indicated that GAD is indeed an enzyme highly sensitive to the effect of HBO exposure. The rapid reduction in GAD67 content may be very closely related to seizures induced by HBO exposure.
Li
Quan
Q
Department of Diving Medicine, Faculty of Naval Medicine, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Guo
Meili
M
Xu
Xiongfei
X
Xiao
Xiang
X
Xu
Weigang
W
Sun
Xuejun
X
Tao
Hengyi
H
Li
Runping
R
D000818:Animals; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D006931:Hyperbaric Oxygenation; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000201:enzymology / Q000209:etiology*
D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1
Aviat Space Environ Med. 1975 Sep;46(9):1155-6
1164354
Neurochem Res. 1991 Mar;16(3):235-42
1780026
Ukr Biokhim Zh (1978). 1978 Sep-Oct;50(5):573-5
726092
J Neurophysiol. 2002 Apr;87(4):2167-75
11929934
Trends Pharmacol Sci. 1998 Dec;19(12):500-5
9871412
Brain Res Mol Brain Res. 1999 Aug 25;71(2):325-31
10521586
Neurochem Res. 1991 Mar;16(3):215-26
1780024
Brain Res. 1993 Mar 19;606(1):56-62
8462004
Neuroscience. 1999;93(4):1375-81
10501462
Undersea Biomed Res. 1979 Jun;6(2):167-74
531996
J Neurochem. 1981 Nov;37(5):1125-9
7299391
J Immunol Methods. 1989 May 12;119(2):203-10
2470825
J Comp Neurol. 1998 May 4;394(2):252-69
9552130
Pharmacol Toxicol. 1992 Apr;70(4):271-7
1608912
J Comp Neurol. 1998 Jun 1;395(2):177-94
9603371
Neurochem Int. 2003 Jun;42(7):549-54
12590937
Neurochem Res. 2005 Aug;30(8):989-1001
16258848
Eur J Pharmacol. 1991 Sep 17;202(2):171-5
1802744
Neurosci Lett. 2000 Nov 3;293(3):159-62
11036185
J Biol Chem. 1997 Sep 26;272(39):24247-51
9305877
Brain Res. 1995 Apr 10;676(2):352-7
7614005
Exp Cell Res. 2004 Jun 10;296(2):223-30
15149852
J Neurochem. 1969 Mar;16(3):281-7
5795581
J Neurochem. 1971 Dec;18(12):2553-5
5135911
Neurosci Lett. 2003 Dec 15;353(1):69-71
14642440
J Biochem. 1982 Feb;91(2):443-8
7068570
Vopr Med Khim. 1978 Jan-Feb;24(1):42-6
664482
J Biomed Sci. 2001 Jul-Aug;8(4):359-64
11455199
J Neurosci. 1994 Dec;14(12):7469-77
7996188
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3073-7
8464926
Neuroscience. 1995 Dec;69(3):705-9
8596641
J Chromatogr. 1981 Sep 11;225(1):37-45
6117564
Biochem Pharmacol. 1973 Feb 15;22(4):501-5
4348060
Eur J Biochem. 1985 Jul 1;150(1):53-60
2862040
Int J Dev Neurosci. 1997 Feb;15(1):127-37
9099623